Disorders of the Ras pathway: An introduction

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 157, Issue 2, 2011, Pages 79-82

  Viskochil, David H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CBL PROTEIN; GENOMIC DNA; GUANOSINE TRIPHOSPHATASE; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NEUROFIBROMIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAF PROTEIN; RAS PROTEIN; SOS PROTEIN;

ANGIOOSTEOHYPERTROPHY SYNDROME; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; BLADDER CANCER; BONE ATROPHY; CANCER CELL; CARCINOGENESIS; CARDIOFACIOCUTANEOUS SYNDROME; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOME 12; CHROMOSOME 17; COSTELLO SYNDROME; EDITORIAL; ENZYME ACTIVITY; ERYTHROBLASTOSIS; FIBROBLAST; GENE IDENTIFICATION; GENE MAPPING; GENOTYPE; HARVEY SARCOMA ONCOVIRUS; HUMAN; HYDROLYSIS; INOCULATION; KIRSTEN SARCOMA ONCOVIRUS; LEGIUS SYNDROME; LEOPARD SYNDROME; LEUKEMIA; LUNG CARCINOMA; MOLONEY LEUKEMIA ONCOVIRUS; MULTIPLE MALFORMATION SYNDROME; MYELOPROLIFERATIVE DISORDER; NEUROBLASTOMA; NEUROFIBROMATOSIS; NONHUMAN; NOONAN SYNDROME; ONCOGENE; PHENOTYPE; PHOSPHORYLATION; POINT MUTATION; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; RETROVIRUS; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; SOLID TUMOR; TISSUE CULTURE; VIRUS GENE; VIRUS ISOLATION;

ABNORMALITIES, MULTIPLE; ANIMALS; GENETIC DISEASES, INBORN; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION;

EID: 79955021077     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30301     Document Type: Editorial

References (32)

1. Allanson JE, Hall JG, Van Allen MI. 1985. Noonan phenotype associated with neurofibromatosis. Am J Med Genet 21: 457-462.
2. Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y. 2008. The RAS/MAPK syndromes: Novel roles of the Ras pathway in human genetic disorders. Hum Mutation 29: 992-1006.
3. Carey JC. 1998. Neurofibromatosis-Noonan syndrome. Am J Med Genet 75: 263-264.
4. Chang EH, Gonda MA, Ellis RW, Scolnick EM, Lowy DR. 1982. Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci USA 79: 4848-4852.
5. Colley A, Donnai D, Evans DGR. 1996. Neurofibromatosis/Noonan phenotype: A variable feature of type 1 neurofibromatosis. Clin Genet 49: 59-64.
6. De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, Schirinzi A, Conti E, Zampino G, Battaglia A, Majore S, Rinaldi MM, Carella M, Marino B, Pizzuti A, Digilio MC, Tartaglia M, Dallapiccola B. 2005. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am J Hum Genet 77: 1092-1101.
7. DeFeo D, Gonda MA, Young HA, Chang EH, Lowy DR, Scolnick EM, Ellis RW. 1981. Proc Natl Acad Sci USA 78: 3328-3332.
8. Denayer E, Legius E. 2007. What's new in the neuro-cardio-facial-cutaneous syndromes? Eur J Pediatr 166: 1091-1098.
9. Ellis RW, DeFeo D, Shih TY, Gonda MA, Young HA, Tsuchida N, Lowy DR, Scolnick EM. 1981. The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature 292: 506-511.
10. Epstein MA. 1958. Observations on the Rous virus; Purification and identification of the particles from solid tumors. Br J Cancer 12: 248-255.
11. Gelb BD, Tartaglia M. 2006. Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction. Hum Mol Genet 15: R220-R226.
12. Gross L. 1951. "Spontaneous" leukemia developing in C3H mice following inoculation, in infancy, with Ak-leukemic extracts, or Ak-embryos. Proc Soc Exptl Biol Med 76: 27-32.
13. Harvey JJ. 1964. An unidentified virus which causes the rapid production of tumours in mice. Nature 2004: 1104-1105.
14. Kirsten WH, Mayer LA. 1967. Morphologic responses to a murine erythroblastosis virus. J Natl Cancer Inst 39: 311-335.
15. Martin G, Viskochil D, Bollag G, McCabe P, Crosier W, Haubruck H, Conroy L, Clark R, O'Connell P, Cawthon R, Innis M, McCormick F. 1990. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63: 843-849.
16. Mendez HMM. 1985. The neurofibromatosis-Noonan syndrome. Am J Med Genet 21: 471-476.
17. Moloney JB. 1964. The rodent leukemias: Virus-induced murine leukemias. Annu Rev Med 15: 383-392.
18. Noonan JA. 1968. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child 116: 373-380.
19. Opitz JM, Weaver DD. 1985. Editorial comment: The Neurofibromatosis-Noonan syndrome. Am J Med Genet 21: 477-490.
20. Pulciani S, Santos E, Lauver AV, Long LK, Robbins KC, Marbacid M. 1982. Oncogenes in human tumor cell lines: Molecular cloning of a transforming gene from human bladder carcinoma cells. Proc Natl Acad Sci USA 79: 2845-2849.
21. Reinker RA, Stevenson DA, Tsung A. 2011. Orthopaedic conditions in Ras/MAPK related disorders. J Pediatr Orthop (in press).
22. Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Della Porta G, Barbacid M. 1984. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science 223: 661-664.
23. Schubbert S, Bollag G, Shannon K. 2007. Deregulated Ras signaling in developmental disorders: New tricks for an old dog. Curr Opin Genet Dev 17: 15-22.
24. Shih TY, Weeks MO, Young HA, Scolnick EM. 1979. Identification of a sarcoma virus coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus. Virology 96: 64-79.
25. Shimizu K, Goldfarb M, Perucho M, Wigler M. 1983. Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line. Proc Natl Acad Sci USA 80: 383-387.
26. Swensen J, Viskochil D. 2008. The RAS pathway. In: Epstein, C., Erickson, R., Wynshaw-Boris, A. editors. Inborn Errors of Development. Oxford Press: London.
27. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, Van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. 2001. Mutation in PTPN11, encoding the protein tyrosine phosphatase SHP-2 cause Noonan syndrome. Nat Genet 29: 465-468.
28. Tassabehji M, Strachan T, Sharland M, Colley A, Donnai D, Harris R, Thakker N. 1993. Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet 53: 90-95.
29. Tidyman WE, Rauen KA. 2009. The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 19: 230-236.
30. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, White R, O'Connell P. 1990. Deletions and translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62: 187-192.
31. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL. 1990. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249: 181-186.
32. Xu G, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, Weiss R. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608.